Cargando…
Wenxin Keli versus Sotalol for Paroxysmal Atrial Fibrillation Caused by Hyperthyroidism: A Prospective, Open Label, and Randomized Study
We aimed to compare effectiveness of Wenxin Keli (WK) and sotalol in assisting sinus rhythm (SR) restoration from paroxysmal atrial fibrillation (PAF) caused by hyperthyroidism, as well as in maintaining SR. We randomly prescribed WK (18 g tid) or sotalol (80 mg bid) to 91 or 89 patients. Since it w...
Autores principales: | Meng, Zhaowei, Tan, Jian, He, Qing, Zhu, Mei, Li, Xue, Zhang, Jianping, Jia, Qiang, Wang, Shen, Zhang, Guizhi, Zheng, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449914/ https://www.ncbi.nlm.nih.gov/pubmed/26074982 http://dx.doi.org/10.1155/2015/101904 |
Ejemplares similares
-
An Overview of Systematic Reviews on the Effectiveness of Wenxin Keli in the Treatment of Atrial Fibrillation
por: Wang, Yuanping, et al.
Publicado: (2022) -
Wenxin Keli for atrial fibrillation: Protocol for a systematic review and meta-analysis
por: He, Zhuogen, et al.
Publicado: (2018) -
Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation
por: Zhang, Nixiao, et al.
Publicado: (2018) -
The Effects of Wenxin Keli on P-Wave Dispersion and Maintenance of Sinus Rhythm in Patients with Paroxysmal Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials
por: Chen, Yu, et al.
Publicado: (2013) -
Molecular Targets and Pathways Contributing to the Effects of Wenxin Keli on Atrial Fibrillation Based on a Network Pharmacology Approach
por: Zhang, Yujie, et al.
Publicado: (2020)